Literature DB >> 9874066

Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.

M Berger1, P Schweitzer.   

Abstract

Pooled data from 32 studies were reviewed to assess the timing of thrombolic complications after cardioversion of atrial fibrillation or flutter. We found that 98% of embolic episodes occurred within 10 days of cardioversion.

Entities:  

Mesh：

Year:  1998        PMID： 9874066     DOI： 10.1016/s0002-9149(98)00704-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  29 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

Review 3.  Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.

Authors:  Daniel Caldeira; João Costa; Joaquim J Ferreira; Gregory Y H Lip; Fausto J Pinto
Journal:  Clin Res Cardiol       Date:  2015-02-03       Impact factor: 5.460

Review 4.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 5.  Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies.

Authors:  Isaac B Rhea; Alexander R Lyon; Michael G Fradley
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

6.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

7.  Anticoagulation for Atrial Fibrillation after Resolution of Dengue Haemorrhagic Fever.

Authors:  Henrique Horta Veloso
Journal:  J Clin Diagn Res       Date:  2016-03-01

8.  Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset.

Authors:  Aatish Garg; Monica Khunger; Sinziana Seicean; Mina K Chung; Patrick J Tchou
Journal:  JACC Clin Electrophysiol       Date:  2016-04-06

9.  Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.

Authors:  Michael S Wu; James Gabriels; Mohammad Khan; Nada Shaban; Salvatore A D'Amato; Christopher F Liu; Steven M Markowitz; James E Ip; George Thomas; Parmanand Singh; Bruce B Lerman; Apoor Patel; Jim W Cheung
Journal:  J Interv Card Electrophysiol       Date:  2018-08-04       Impact factor: 1.900

Review 10.  Emergency management of atrial fibrillation.

Authors:  A Wakai; J O O'Neill
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.